WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

M MUSCULO-SKELETAL SYSTEM
M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN

This group comprises ointments, liniments, plasters, etc. which may produce symptomatic relief in joint and muscular pain.

No DDDs have been assigned in this group.


M02AA Antiinflammatory preparations, non-steroids for topical use

All non-steroidal antiinflammatory derivatives for topical use are classified here, regardless of indication. Exception is a product containing diclofenac formulated as a 3% hyaluronic acid gel which is used in treatment of actinic keratoses. This particular formulation is classified in D11AX.

Combinations of non-steroidal antiinflammatory derivatives and other substances for topical use are classified together with plain preparations at the different 5th levels.

M02AB Capsaicin and similar agents

Capsaicin products indicated for the symptomatic treatment of peripheral neuropathic pain (incl. postherpetic neuralgia) are classified in N01BX.

Combined preparations containing nonivamide used as a rubefacient are classified in this group on a 4th level.

M02AC Preparations with salicylic acid derivatives

No separate 5th levels are established in this group.

Combinations of salicylic acid derivatives and other products are classified in this group.

M02AX Other topical products for joint and muscular pain

This group comprises topical products, which cannot be classified in the preceding groups.

Preparations with menthol are generally classified in D04 - Antipruritics, incl. antihistamines, anesthetics, etc.

Last updated: 2018-12-13